• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD24影响前B淋巴细胞和乳腺癌细胞中CXCR4的功能。

CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.

作者信息

Schabath Heidi, Runz Steffen, Joumaa Safwan, Altevogt Peter

机构信息

Tumor Immunology Programme, D010, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

出版信息

J Cell Sci. 2006 Jan 15;119(Pt 2):314-25. doi: 10.1242/jcs.02741. Epub 2006 Jan 3.

DOI:10.1242/jcs.02741
PMID:16390867
Abstract

CD24 is a small, heavily glycosylated cell-surface protein which is linked to the membrane via a glycosyl-phosphatidylinositol (GPI-) anchor and therefore localizes in lipid rafts. CD24 is widely used as a cell-lineage marker for hematopoietic cells. CD24 is also expressed on a variety of human carcinomas, including epithelial ovarian, breast, prostate, colon and lung cancer and has been linked to poor prognosis. Except for its role as a ligand for P-selectin on carcinoma and myeloid cells, a specific function for CD24 has not been determined. Here we show that CD24 affects the function of the chemokine receptor CXCR4. Using isolated CD19-positive bone marrow B cells from CD24-knockout mice and CD24-/- pre-B lymphocytic cell lines, we demonstrate that CD24 expression reduces SDF-1-mediated cell migration and signalling via CXCR4. We observed that the loss of CD24 augmented cellular cholesterol levels and enhanced CXCR4 lipid raft association. Altered chemotactic migration and raft residence was also observed in MDA-MB-231 breast cancer cells expressing high and low levels of CD24 and CXCR4 receptor. MDA-MB-231 cells expressing low levels of CD24 also showed enhanced tumour formation in NOD/SCID mice compared with cells overexpressing CD24. These results demonstrate a novel role for CD24 as a regulator of CXCR4 function that could be relevant for breast cancer growth and metastasis.

摘要

CD24是一种小的、高度糖基化的细胞表面蛋白,它通过糖基磷脂酰肌醇(GPI-)锚定与细胞膜相连,因此定位于脂筏中。CD24被广泛用作造血细胞的细胞谱系标志物。CD24也在多种人类癌症中表达,包括上皮性卵巢癌、乳腺癌、前列腺癌、结肠癌和肺癌,并且与预后不良有关。除了作为癌和髓样细胞上P-选择素的配体发挥作用外,CD24的具体功能尚未确定。在此我们表明,CD24影响趋化因子受体CXCR4的功能。使用从CD24基因敲除小鼠分离的CD19阳性骨髓B细胞和CD24 - / - 前B淋巴细胞系,我们证明CD24的表达减少了SDF-1介导的通过CXCR4的细胞迁移和信号传导。我们观察到CD24的缺失增加了细胞胆固醇水平并增强了CXCR4与脂筏的结合。在表达高水平和低水平CD24和CXCR4受体的MDA-MB-231乳腺癌细胞中也观察到趋化迁移和脂筏驻留的改变。与过表达CD24的细胞相比,表达低水平CD24的MDA-MB-231细胞在NOD/SCID小鼠中也显示出增强的肿瘤形成。这些结果证明了CD24作为CXCR4功能调节剂的新作用,这可能与乳腺癌的生长和转移有关。

相似文献

1
CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.CD24影响前B淋巴细胞和乳腺癌细胞中CXCR4的功能。
J Cell Sci. 2006 Jan 15;119(Pt 2):314-25. doi: 10.1242/jcs.02741. Epub 2006 Jan 3.
2
Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.对基质细胞衍生因子-1进行基因操作证明了自分泌SDF-1-CXCR4通路在乳腺癌细胞侵袭性中的关键作用。
Int J Oncol. 2005 May;26(5):1429-34.
3
A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.一种具有高CD44+CD24-/低表型转移至人骨特性的人乳腺癌干细胞新型小鼠模型。
Chin Med J (Engl). 2008 Oct 20;121(20):1980-6.
4
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.CXCL12/CXCR4信号通路激活前列腺癌细胞中Akt-1和MMP-9的表达:骨微环境相关CXCL12的作用
Prostate. 2006 Jan 1;66(1):32-48. doi: 10.1002/pros.20318.
5
Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.人前列腺癌中基质细胞衍生因子-1与CXC趋化因子受体4之间配体-受体系统的相互作用:转移的一种可能预测指标
Biochem Biophys Res Commun. 2004 Jul 30;320(3):656-63. doi: 10.1016/j.bbrc.2004.06.013.
6
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.基质细胞衍生因子-1与CXCR4受体相互作用在乳腺癌肿瘤生长和转移中的作用
Biomed Pharmacother. 2006 Jul;60(6):273-6. doi: 10.1016/j.biopha.2006.06.004. Epub 2006 Jun 28.
7
Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.趋化因子受体CXCR4的差异性功能激活由乳腺癌细胞中的G蛋白介导。
Cancer Res. 2006 Apr 15;66(8):4117-24. doi: 10.1158/0008-5472.CAN-05-1631.
8
Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells.ω-3多不饱和脂肪酸下调MDA-MB-231乳腺癌细胞中CXCR4的表达及功能。
Mol Cancer Res. 2009 Jul;7(7):1013-20. doi: 10.1158/1541-7786.MCR-08-0385. Epub 2009 Jun 30.
9
CD24 induces localization of beta1 integrin to lipid raft domains.CD24诱导β1整合素定位至脂筏结构域。
Biochem Biophys Res Commun. 2008 Jan 4;365(1):35-41. doi: 10.1016/j.bbrc.2007.10.139. Epub 2007 Nov 1.
10
Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.两种转移性乳腺癌细胞的跨内皮迁移依赖于基质细胞衍生因子-1α-趋化因子受体4复合物。
Anticancer Res. 2004 Nov-Dec;24(6):4011-7.

引用本文的文献

1
Targeting "don't eat me" signal: breast cancer immunotherapy.靶向“别吃我”信号:乳腺癌免疫疗法
Breast Cancer Res Treat. 2025 Jun;211(2):277-292. doi: 10.1007/s10549-025-07659-w. Epub 2025 Mar 18.
2
Evaluation of the anticancer effects of hydroxycinnamic acid isomers on breast cancer stem cells.羟基肉桂酸异构体对乳腺癌干细胞抗癌作用的评估。
Med Oncol. 2025 Feb 11;42(3):73. doi: 10.1007/s12032-025-02618-3.
3
Differences in CD24 Expression Between Prostate Adenocarcinoma and Benign Prostatic Hyperplasia: A Cross-sectional Study.
前列腺腺癌与良性前列腺增生之间CD24表达的差异:一项横断面研究。
Iran J Pathol. 2024;19(3):306-310. doi: 10.30699/ijp.2024.2021959.3251. Epub 2024 Jul 24.
4
Navigating the Intricacies of Tumor Heterogeneity: An Insight into Potential Prognostic Breast Cancer Biomarkers.探索肿瘤异质性的复杂性:深入了解潜在的乳腺癌预后生物标志物
Biomark Insights. 2024 Jun 17;19:11772719241256798. doi: 10.1177/11772719241256798. eCollection 2024.
5
Editorial: CD24 in the regulation of cellular development and disease.社论:CD24在细胞发育和疾病调控中的作用
Front Immunol. 2024 Feb 27;15:1374701. doi: 10.3389/fimmu.2024.1374701. eCollection 2024.
6
Targeting CD24 in Cancer Immunotherapy.癌症免疫治疗中靶向CD24
Biomedicines. 2023 Nov 27;11(12):3159. doi: 10.3390/biomedicines11123159.
7
Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer.鉴定与乳腺癌预后和免疫浸润相关的外泌体特征。
Sci Rep. 2023 Oct 24;13(1):18198. doi: 10.1038/s41598-023-45325-7.
8
Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients.乳腺癌患者中乳腺癌干细胞(BCSCs)不同表型亚群的基因谱分析。
Cancer Cell Int. 2022 Dec 31;22(1):423. doi: 10.1186/s12935-022-02841-2.
9
RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer.基于 RNA 的乳腺癌种族多样化患者同源重组缺陷分类。
Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2136-2147. doi: 10.1158/1055-9965.EPI-22-0590.
10
CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection.CD24表达抑制人神经母细胞瘤细胞的基础抗病毒状态并增强对寨卡病毒感染的易感性。
Viruses. 2022 Aug 6;14(8):1735. doi: 10.3390/v14081735.